Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

937622

registered interest
date	09/07/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Antimicrobials: Drug Resistance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, for what reason Tuberculosis was excluded from the scope of the £10 million Small Business Research Initiative competition on antimicrobial resistance in humans.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	162105
answer	answer is ministerial correction date of answer 12/07/2018 answer text <p>The Small Business Research Initiative competition is funded by a Department of Health and Social Care non-Official Development Assistance budget. Research specifically on Tuberculosis (TB) pathogens was deprioritised for this competition as there are established global funds targeting the development of new treatments for TB.</p><p> </p><p>The United Kingdom is contributing to a reduction in drug resistant TB by implementing the Collaborative TB Strategy for England, which parallels and integrates with the aims and actions of the UK Antimicrobial Resistance strategy.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/07/2018 11:45:18 answering member 4067 label Biography information for Steve Brine
tabling member	4488 label Biography information for Martyn Day

846084

registered interest
date	21/02/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Rare Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to his Department's policy paper, UK strategy for rare diseases: implementation plan for England, published on 29 January 2018, what steps he is taking to increase cross-border collaboration (a) within the UK and (b) between the UK and the EU in developing approaches to treatment and management of rare diseases.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	128792
answer	answer is ministerial correction date of answer 01/03/2018 answer text <p>The activities described in the Department’s ‘UK Strategy for Rare Diseases: implementation plan for England’ are those that are shared between the Department and a number of partner organisations in implementing the UK Strategy for Rare Diseases. This implementation plan applies to England only.</p><p> </p><p>The UK Rare Disease Policy Board, which has representation of all four United Kingdom nations, oversees the implementation of the UK Strategy for Rare Diseases across the UK. The UK Rare Disease Policy Board publishes on a biennial basis an update on the implementation activities across the whole of the UK. The next report was published on 28 February 2018 and will highlight, in greater detail, initiatives and achievements across the four nations over the past two years, as well as look at UK-wide developments and challenges in the rare diseases landscape that will be important in the forward look to 2020.</p><p> </p><p>The UK is involved in European Reference Networks, virtual centres of knowledge, skills and expertise in the field of rare diseases and complex conditions, which provide a platform to create partnerships between healthcare providers. The UK participates in 23 out of the 24 networks (involving 113 separate UK groups) and leads six networks.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 01/03/2018 15:08:15 answering member 4067 label Biography information for Steve Brine
tabling member	4488 label Biography information for Martyn Day

846086

registered interest
date	21/02/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Orphan Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that NHS England and NICE revise their appraisal criteria for the NICE Highly Specialised Technologies as a result of the Scottish Medicines Consortium’s review of the definition of orphan and ultra-orphan designation route to include condition prevalence criteria; and if he will ensure that they publish those prevalence criteria.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	128793
answer	answer is ministerial correction date of answer 01/03/2018 answer text <p>The Government and the National Institute for Health and Care Excellence (NICE) have no plans to review the criteria for the selection of topics for referral to NICE’s Highly Specialised Technologies (HST) programme. The topic selection criteria for HST are published at:</p><p> </p><p><a href="https://www.nice.org.uk/about/what-we-do/our-programmes/topic-selection" target="_blank">https://www.nice.org.uk/about/what-we-do/our-programmes/topic-selection</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 01/03/2018 15:09:31 answering member 4067 label Biography information for Steve Brine
tabling member	4488 label Biography information for Martyn Day

846144

registered interest
date	21/02/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Patients: Death
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what guidelines his Department has in place for medical staff dealing with hospital deaths where the deceased has requested to be preserved using cryonics.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	128838
answer	answer is ministerial correction date of answer 28/02/2018 answer text <p>The Department has not issued guidance to medical staff dealing with hospital deaths where the deceased has requested to be preserved using cryogenics. There are no current plans to amend the Human Tissue Act or bring forward legislative proposals in this area.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 128839 128840 question first answered 28/02/2018 14:53:51 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4488 label Biography information for Martyn Day

846145

registered interest
date	21/02/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Tissue (Quality and Safety for Human Application) (Amendment) Regulations 2018
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will amend the draft Human Tissue (Quality and Safety for Human Application) (Amendment) Regulations 2018 to include the regulation of cryopreservation of (a) complete bodies and (b) heads.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	128839
answer	answer is ministerial correction date of answer 28/02/2018 answer text <p>The Department has not issued guidance to medical staff dealing with hospital deaths where the deceased has requested to be preserved using cryogenics. There are no current plans to amend the Human Tissue Act or bring forward legislative proposals in this area.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 128838 128840 question first answered 28/02/2018 14:53:51 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4488 label Biography information for Martyn Day

846146

registered interest
date	21/02/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Tissue (Quality and Safety for Human Application) (Amendment) Regulations 2018
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make it his policy to bring forward legislative proposals for the regulation by the Human Tissue Authority on the removal of (a) bodies and (b) heads for cryopreservation.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	128840
answer	answer is ministerial correction date of answer 28/02/2018 answer text <p>The Department has not issued guidance to medical staff dealing with hospital deaths where the deceased has requested to be preserved using cryogenics. There are no current plans to amend the Human Tissue Act or bring forward legislative proposals in this area.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 128838 128839 question first answered 28/02/2018 14:53:51 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4488 label Biography information for Martyn Day

845522

registered interest
date	20/02/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	WHO Framework Convention on Tobacco Control
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when the Government plans to (a) ratify the WHO Framework Convention on Tobacco Control and (b) deposit the instrument of ratification at the UN in New York.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	128494
answer	answer is ministerial correction date of answer 23/02/2018 answer text <p>The United Kingdom ratified the World Health Organization Framework Convention on Tobacco Control (WHO FCTC) on the 16 December 2004. The WHO FCTC adopted the Protocol to Eliminate Illicit Trade in Tobacco Products on 12 November 2012. The Government is fully committed to the Protocol. It is current UK Government policy that international treaties will not be ratified until all the legislation required for implementation has been passed by Parliament. A Command Paper setting out the UK’s plans to ratify the World Health Organization Protocol to Eliminate Illicit Trade in Tobacco Products now needs to be laid before Parliament. Preparations, led by HM Revenue and Customs, are underway and they expect to proceed shortly.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/02/2018 12:17:57 answering member 4067 label Biography information for Steve Brine
tabling member	4488 label Biography information for Martyn Day

834613

registered interest
date	01/02/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ankylosing Spondylitis and Arthritis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 22 December to Question 119911 on Ankylosing Spondylitis and Arthritis , when NHS England plans to announce its next steps in relation to the recommendations it was presented with on 1 December 2017 by the data advisory group, led by Arthritis Research UK; and whether there will be a wider consultation on the opportunities for improved routine data collection on musculoskeletal incidence, prevalence, clinical activity, and outcomes.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	126061
answer	answer is ministerial correction date of answer 08/02/2018 answer text <p>NHS England’s work to consider the recommendations of the data advisory group is ongoing. Information on the next steps will be available in due course.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/02/2018 14:48:37 answering member 4067 label Biography information for Steve Brine
tabling member	4488 label Biography information for Martyn Day

819795

registered interest
date	10/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Spondyloarthritis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what mechanisms have been put in place to identify accurately the number of individuals diagnosed with ankylosing spondylitis and psoriatic arthritis within the NHS in England.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	121867
answer	answer is ministerial correction date of answer 18/01/2018 answer text <p>Improving Lives - The Work, Health and Disability Green Paper, published on 31 October 2016, sets out the Government’s commitment to work with NHS England to identify opportunities for regular collection of data about incidence, prevalence, clinical activity and outcomes of musculoskeletal (MSK) conditions and services in England. The Government’s Mandate to NHS England reiterated this commitment.</p><p> </p><p>On 30 November 2017, the Government published Improving Lives - The Future of Work, Health and Disability in response to the Green Paper. This builds on the commitment to identify opportunities for routine data collection about MSK incidence, prevalence, clinical activity, and outcomes. The report outlined that a data advisory group, led by Arthritis Research UK, has been examining the issue. On 1 December 2017, the advisory group presented its recommendations to NHS England, which is currently considering the appropriate next steps.</p><p> </p><p>Improving Lives - The Future of Work, Health and Disability can be found at the following link:</p><p> </p><p><a href="http://www.gov.uk/government/publications/improving-lives-the-future-of-work-health-and-disability" target="_blank">www.gov.uk/government/publications/improving-lives-the-future-of-work-health-and-disability</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/01/2018 14:07:08 answering member 4067 label Biography information for Steve Brine
tabling member	4488 label Biography information for Martyn Day

810508

registered interest
date	21/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Chronic Fatigue Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking as a result of the latest evidence on the diagnosis and treatment of Chronic Fatigue Syndrome.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	120854
answer	answer is ministerial correction date of answer 12/01/2018 answer text <p>The National Institute for Health and Care Excellence (NICE) is the independent expert body responsible for developing robust, evidence based guidance for the National Health Service to support it in designing services that are in line with the best available evidence.</p><p> </p><p>The NICE guideline Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): Diagnosis and management of CFS/ME in adults and children sets outs best practice for clinicians on the diagnosis, treatment, care and support of people with the condition and assists commissioners in planning services for local populations. The full guideline can be found at the following link:</p><p><a href="http://www.nice.org.uk/guidance/cg53" target="_blank">www.nice.org.uk/guidance/cg53</a></p><p>NICE routintely reviews its guidance to ensure it reflects the lastest available evidence. On 20 September 2017, NICE announced its decision to undertake a full update of the CFS/ME guidance. More information on this decision can be found at the following link:</p><p><a href="http://www.nice.org.uk/guidance/cg53/resources/surveillance-report-2017-chronic-fatigue-syndromemyalgic-encephalomyelitis-or-encephalopathy-diagnosis-and-management-2007-nice-guideline-cg53-pdf-5964455783941" target="_blank">www.nice.org.uk/guidance/cg53/resources/surveillance-report-2017-chronic-fatigue-syndromemyalgic-encephalomyelitis-or-encephalopathy-diagnosis-and-management-2007-nice-guideline-cg53-pdf-5964455783941</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/01/2018 11:23:31 answering member 4067 label Biography information for Steve Brine
tabling member	4488 label Biography information for Martyn Day